Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM)

CUSIP: 690145206

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value of $0.001 per share
Shares outstanding
18,116,200
Total 13F shares
14,676,599
Share change
+14,676,568
Total reported value
$162,319,841
Put/Call ratio
107%
Price per share
$11.06
Number of holders
59
Value change
+$162,319,498
Number of buys
57

Quarterly Holders Quick Answers

What is CUSIP 690145206?
CUSIP 690145206 identifies OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Durable Capital Partners LP
13D/G
9.9%
26,609,101
$154,630,808 $0 03 Jan 2025
FMR LLC
13D/G 13F
Company
14%
2,596,861
$30,149,556 $0 31 Mar 2025
Woodline Partners LP
13D/G
7.5%
1,325,784
$15,392,352 $0 31 Mar 2025
PERCEPTIVE ADVISORS LLC
13D/G
6.7%
1,208,334
$14,028,758 $0 31 Mar 2025
Alyeska Investment Group, L.P.
13D/G
9.6%
1,703,083
$9,896,956 $0 31 Mar 2025
VANGUARD GROUP INC
13F
Company
14%
2,608,902
$2,895,881 31 Dec 2024
13F
GMT CAPITAL CORP
13F
Company
8%
1,471,706
$1,633,594 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
7.8%
1,436,272
$1,594,261 31 Dec 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
7.6%
1,393,250
$1,546,508 31 Dec 2024
13F
Ensign Peak Advisors, Inc
13F
Company
7.1%
1,291,154
$1,433,181 31 Dec 2024
13F
Steven S. Williamson
3/4/5
Chief Commercial Officer
class O/S missing
320,347
$1,143,639 15 Feb 2024
ACADIAN ASSET MANAGEMENT LLC
13F
Company
5.5%
1,006,483
$1,115,000 31 Dec 2024
13F
C WorldWide Group Holding A/S
13F
Company
5.5%
1,000,000
$1,110,000 31 Dec 2024
13F
GSA CAPITAL PARTNERS LLP
13F
Company
5.2%
959,440
$1,065,000 31 Dec 2024
13F
BlackRock, Inc.
13F
Company
5.1%
938,357
$1,041,577 31 Dec 2024
13F
Jean-Olivier Racine
3/4/5
Chief Technology Officer
class O/S missing
265,325
$867,613 10 May 2024
RENAISSANCE TECHNOLOGIES LLC
13F
Company
3.8%
686,748
$762,290 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
3.1%
563,763
$626,164 31 Dec 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
2.7%
488,602
$542,348 31 Dec 2024
13F
DEUTSCHE BANK AG\
13F
Company
2.3%
417,477
$463,399 31 Dec 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
2.3%
412,500
$457,875 31 Dec 2024
13F
Martin Vazquez
3/4/5
Chief Operating Officer
mixed-class rows
146,619
mixed-class rows
$442,350 01 Mar 2023
Birchview Capital, LP
13F
Company
2%
368,766
$409,330 31 Dec 2024
13F
Assenagon Asset Management S.A.
13F
Company
1.6%
289,783
$321,659 31 Dec 2024
13F
James F. Hinrichs.
3/4/5
Director
class O/S missing
80,349
$283,632 29 May 2024
Stacey L. Porter
3/4/5
Chief People Officer
class O/S missing
61,448
$263,612 12 Jan 2024
STATE STREET CORP
13F
Company
1%
189,973
$210,870 31 Dec 2024
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.99%
180,444
$200,293 31 Dec 2024
13F
Squarepoint Ops LLC
13F
Company
0.86%
156,787
$174,034 31 Dec 2024
13F
Dale E. Jones
3/4/5
Director
class O/S missing
45,918
$162,091 29 May 2024
JANE STREET GROUP, LLC
13F
Company
0.6%
109,078
$121,077 31 Dec 2024
13F
GROUP ONE TRADING LLC
13F
Company
0.56%
103,106
$114,448 31 Dec 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.55%
100,000
$111,000 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
0.54%
99,124
$110,028 31 Dec 2024
13F
Catherine M. Szyman
3/4/5
Director
class O/S missing
24,596
$105,517 31 May 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.51%
92,936
$103,159 31 Dec 2024
13F
UBS Group AG
13F
Company
0.5%
91,909
$102,019 31 Dec 2024
13F
Invesco Ltd.
13F
Company
0.5%
91,084
$101,103 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.45%
81,766
$90,760 31 Dec 2024
13F
Corient Private Wealth LLC
13F
Company
0.33%
61,129
$67,853 31 Dec 2024
13F
HUNTINGTON NATIONAL BANK
13F
Company
0.31%
57,306
$63,610 31 Dec 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0.31%
56,841
$63,000 31 Dec 2024
13F
Rebecca Chambers
3/4/5
Chief Financial Officer
mixed-class rows
91,342
mixed-class rows
$58,331 24 Jun 2021
NATIONAL BANK OF CANADA /FI/
13F
Company
0.27%
50,044
$55,549 31 Dec 2024
13F
XTX Topco Ltd
13F
Company
0.25%
45,315
$50,300 31 Dec 2024
13F
Harbor Advisors LLC
13F
Company
0.25%
45,000
$49,950 31 Dec 2024
13F
GRIFFIN ASSET MANAGEMENT, INC.
13F
Company
0.24%
44,475
$49,367 31 Dec 2024
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.23%
42,477
$47,149 31 Dec 2024
13F
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO
13F
Company
0.23%
42,164
$47,000 31 Dec 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.21%
39,300
$44,000 31 Dec 2024
13F

Institutional Holders of Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) as of Q1 2025

As of 31 Mar 2025, Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,676,599 shares. The largest 10 holders included FMR LLC, Durable Capital Partners LP, Alyeska Investment Group, L.P., PFM Health Sciences, LP, T. Rowe Price Investment Management, Inc., Woodline Partners LP, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, PERCEPTIVE ADVISORS LLC, MARSHALL WACE, LLP, and Parkman Healthcare Partners LLC. This page lists 59 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2025 Across Filers

Q4 2025 holders
93
Q1 2025 holders
59
Holder diff
-34
Investor Q4 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.